Under 7% of dialysis patients are current with COVID vaccines, underscoring the need for antiviral treatments for patients with kidney disease.
Paxlovid tied to lower risk of hospital stay, heart problems, death in adults with kidney disease and COVID
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- US flu season shows signs of peak
- Hospitalized COVID patients at higher risk for organ-related death, readmission for 2.5 years, data suggest
- Liberals’, conservatives’ trust in US government’s use of digital health data diverged during COVID
- Report: COVID survivors nearly twice as likely to have ongoing symptoms as those with flu